5/1/2013 11:41:59 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SOUTH SAN FRANCISCO, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a molecular diagnostics company developing and commercializing quantitative, biology-based tests for rheumatoid arthritis (RA) and other autoimmune diseases, today announced that it has received accreditation from the Commission on Laboratory Accreditation of the College of American Pathologists (CAP) based on the results of an on-site laboratory inspection. The U.S. federal government recognizes the CAP Laboratory Accreditation Program as being equal-to or more-stringent-than the government's own inspection program. This announcement follows the recent laboratory permit issued by the New York Department of Health Clinical Laboratory Evaluation Program (CLEP) to Crescendo Bioscience.
Help employers find you! Check out all the jobs and post your resume.
comments powered by